This page shows Invesco Mort (IVR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
IVR's business mechanic is leveraged balance-sheet expansion, where a larger asset base rather than overhead cuts is driving profit recovery.
From FY2024 to FY2025, net income climbed to$101.3M while operating cash flow fell to$157.1M , so reported profit improved faster than cash generation. With debt-to-equity also moving from 6.8x to 7.1x, the recovery sits on a more leveraged earnings base rather than a more self-funding one.
This is an asset-heavy financing model: FY2025 assets reached
The cost structure looks light on operating overhead, with SG&A near
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Invesco Mort's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Invesco Mort's revenue grew a modest 3.1% year-over-year to $295.3M. This slow but positive growth earns a score of 38/100.
Invesco Mort has elevated debt relative to equity (D/E of 7.12), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
Invesco Mort's ROE of 12.7% shows moderate profitability relative to equity, earning a score of 30/100. This is up from 8.2% the prior year.
Invesco Mort passes 4 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Invesco Mort generates $1.55 in operating cash flow ($157.1M OCF vs $101.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Invesco Mort generated $295.3M in revenue in fiscal year 2025. This represents an increase of 3.1% from the prior year.
Invesco Mort reported $101.3M in net income in fiscal year 2025. This represents an increase of 69.1% from the prior year.
Invesco Mort earned $1.32 per diluted share (EPS) in fiscal year 2025. This represents an increase of 103.1% from the prior year.
Cash & Balance Sheet
Invesco Mort held $56.0M in cash against $0 in long-term debt as of fiscal year 2025.
Invesco Mort had 72M shares outstanding in fiscal year 2025. This represents an increase of 16.3% from the prior year.
Margins & Returns
Invesco Mort's net profit margin was 34.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 13.4 percentage points from the prior year.
Invesco Mort's ROE was 12.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.5 percentage points from the prior year.
Capital Allocation
IVR Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $77.9M+6.8% | $72.9M+3.2% | $70.6M-4.4% | $73.8M-3.0% | $76.1M+3.1% | $73.8M+8.5% | $68.0M-0.8% | $68.6M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $1.8M-2.4% | $1.8M-11.7% | $2.0M+22.7% | $1.7M+3.4% | $1.6M-10.9% | $1.8M-7.1% | $1.9M+8.2% | $1.8M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $56.6M+2.4% | $55.3M+4.6% | $52.9M-3.9% | $55.0M-11.9% | $62.4M-5.9% | $66.3M+11.7% | $59.4M-3.6% | $61.6M |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $51.5M-3.7% | $53.5M+329.2% | -$23.3M-218.8% | $19.6M+460.2% | $3.5M-91.4% | $40.7M+402.4% | -$13.5M-146.2% | $29.1M |
| EPS (Diluted) | N/A | $0.74+285.0% | $-0.40-253.8% | $0.26 | N/A | $0.63+265.8% | $-0.38-177.6% | $0.49 |
IVR Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.5B+8.6% | $6.0B+10.4% | $5.4B-12.3% | $6.2B+8.3% | $5.7B-6.5% | $6.1B+20.0% | $5.1B-3.2% | $5.2B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $56.0M-4.3% | $58.5M-1.4% | $59.4M+38.5% | $42.9M-41.6% | $73.4M+52.1% | $48.3M-17.9% | $58.8M-1.9% | $59.9M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $5.7B+9.4% | $5.2B+10.7% | $4.7B-13.1% | $5.4B+8.9% | $5.0B-5.1% | $5.2B+21.3% | $4.3B-3.1% | $4.4B |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $797.5M+3.6% | $769.6M+8.5% | $709.4M-6.6% | $759.2M+3.9% | $730.7M-14.7% | $857.0M+12.9% | $759.2M-3.4% | $785.6M |
| Retained Earnings | -$3.6B+0.6% | -$3.6B+0.7% | -$3.6B-1.4% | -$3.6B-0.2% | -$3.6B-0.9% | -$3.5B+0.3% | -$3.6B-1.1% | -$3.5B |
IVR Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $59.8M+60.4% | $37.3M-8.2% | $40.6M+110.0% | $19.3M-68.7% | $61.9M+100.6% | $30.8M-6.5% | $33.0M-42.6% | $57.5M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$520.4M+7.7% | -$564.0M-179.7% | $708.0M+237.1% | -$516.5M-228.7% | $401.4M+138.9% | -$1.0B-1175.5% | $95.9M+158.5% | $37.1M |
| Financing Cash Flow | $446.3M-13.7% | $516.9M+169.9% | -$739.6M-258.1% | $467.8M+211.2% | -$420.8M-142.7% | $986.0M+775.5% | -$146.0M-57.4% | -$92.7M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
IVR Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 66.1%-7.2pp | 73.3%+106.4pp | -33.0%-59.6pp | 26.6%+22.0pp | 4.6%-50.5pp | 55.2%+74.9pp | -19.8%-62.2pp | 42.5% |
| Return on Equity | 6.5%-0.5pp | 7.0%+10.2pp | -3.3%-5.9pp | 2.6%+2.1pp | 0.5%-4.3pp | 4.8%+6.5pp | -1.8%-5.5pp | 3.7% |
| Return on Assets | 0.8%-0.1pp | 0.9%+1.3pp | -0.4%-0.8pp | 0.3%+0.3pp | 0.1%-0.6pp | 0.7%+0.9pp | -0.3%-0.8pp | 0.6% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 7.12+0.4 | 6.75+0.1 | 6.61-0.5 | 7.11+0.3 | 6.78+0.7 | 6.10+0.4 | 5.67+0.0 | 5.66 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Invesco Mort's annual revenue?
Invesco Mort (IVR) reported $295.3M in total revenue for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Invesco Mort's revenue growing?
Invesco Mort (IVR) revenue grew by 3.1% year-over-year, from $286.5M to $295.3M in fiscal year 2025.
Is Invesco Mort profitable?
Yes, Invesco Mort (IVR) reported a net income of $101.3M in fiscal year 2025, with a net profit margin of 34.3%.
What is Invesco Mort's net profit margin?
Invesco Mort (IVR) had a net profit margin of 34.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Invesco Mort's return on equity (ROE)?
Invesco Mort (IVR) has a return on equity of 12.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Invesco Mort's operating cash flow?
Invesco Mort (IVR) generated $157.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Invesco Mort's total assets?
Invesco Mort (IVR) had $6.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Invesco Mort's debt-to-equity ratio?
Invesco Mort (IVR) had a debt-to-equity ratio of 7.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Invesco Mort's return on assets (ROA)?
Invesco Mort (IVR) had a return on assets of 1.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Invesco Mort's Piotroski F-Score?
Invesco Mort (IVR) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Invesco Mort's earnings high quality?
Invesco Mort (IVR) has an earnings quality ratio of 1.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Invesco Mort?
Invesco Mort (IVR) scores 11 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.